AAAAAA
Results:
1-24
|
Results: 24
Authors:
HERNBERG M
TURUNEN JP
VONBOGUSLAWSKY K
MUHONEN T
PYRHONEN S
Citation: M. Hernberg et al., PROGNOSTIC VALUE OF BIOMARKERS IN MALIGNANT-MELANOMA, Melanoma research, 8(3), 1998, pp. 283-291
Authors:
JANES RJ
MUHONEN T
KARJALAINEN UP
WIKLUND T
Citation: Rj. Janes et al., URINARY 5-HYDROXYINDOLEACETIC ACID (5-HIAA) EXCRETION DURING MULTIPLE-DAY HIGH-DOSE CHEMOTHERAPY, European journal of cancer, 34(1), 1998, pp. 196-198
Authors:
NYANDOTO P
MUHONEN T
JOENSUU H
Citation: P. Nyandoto et al., 2ND CANCER AMONG LONG-TERM SURVIVORS FROM HODGKINS-DISEASE, International journal of radiation oncology, biology, physics, 42(2), 1998, pp. 373-378
Authors:
HERNBERG M
TURUNEN JP
MUHONEN T
PYRHONEN S
Citation: M. Hernberg et al., TUMOR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY, Journal of immunotherapy, 20(6), 1997, pp. 488-495
Authors:
MUHONEN T
JOKELAINEN K
HOOKNIKANNE J
METHUEN T
SALASPURO M
Citation: T. Muhonen et al., TROPISETRON AND HANGOVER, Addiction biology, 2(4), 1997, pp. 461-462
Authors:
VEHMANEN P
FRIEDMAN LS
EEROLA H
MCCLURE M
WARD B
SARANTAUS L
KAINU T
SYRJAKOSKI K
PYRHONEN S
KALLIONIEMI OP
MUHONEN T
LUCE M
FRANK TS
NEVANLINNA H
Citation: P. Vehmanen et al., LOW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES, Human molecular genetics, 6(13), 1997, pp. 2309-2315
Authors:
HAHKAKEMPPINEN M
MUHONEN T
NORDLING S
PYRHONEN S
Citation: M. Hahkakemppinen et al., DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA, Melanoma research, 7(4), 1997, pp. 329-334
Authors:
HERNBERG M
MUHONEN T
PYRHONEN S
Citation: M. Hernberg et al., CAN THE CD4+ CD8+ RATIO PREDICT THE OUTCOME OF INTERFERON-ALPHA THERAPY FOR RENAL-CELL CARCINOMA/, Annals of oncology, 8(1), 1997, pp. 71-77
Authors:
VILLIKKA K
MUHONEN T
RISTAMAKI R
TEERENHOVI L
JOENSUU H
Citation: K. Villikka et al., STAGE-I NON-HODGKINS-LYMPHOMA TREATED WITH DOXORUBICIN-CONTAINING CHEMOTHERAPY WITH OR WITHOUT RADIOTHERAPY, Acta oncologica, 36(6), 1997, pp. 619-624
Authors:
VLAYKOVA T
MUHONEN T
HAHKAKEMPPINEN M
PYRHONEN S
JEKUNEN A
Citation: T. Vlaykova et al., VASCULARITY AND PROGNOSIS OF METASTATIC MELANOMA, International journal of cancer, 74(3), 1997, pp. 326-329
Authors:
MUHONEN T
EEROLA H
VEHMANEN P
NEVANLINNA H
AKTAN K
BLOMQVIST C
KAARIAINEN H
PYRHONEN S
Citation: T. Muhonen et al., BREAST-CANCER RISK-ESTIMATION IN FAMILIES WITH HISTORY OF BREAST-CANCER, British Journal of Cancer, 76(9), 1997, pp. 1228-1231
Authors:
VEHMANEN P
FRIEDMAN LS
EEROLA H
MCCLURE M
WARD B
SARANTAUS L
KAINU T
SYRJAKOSKI K
PYRHONEN S
KALLIONIEMI OP
MUHONEN T
LUCE M
FRANK TS
NEVANLINNA HA
Citation: P. Vehmanen et al., A LAW PROPORTION OF BRCA1 AND BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES - STRONG EVIDENCE FOR ADDITIONAL SUSCEPTIBILITY GENES, American journal of human genetics, 61(4), 1997, pp. 472-472
Authors:
VEHMANEN P
FRIEDMAN LS
EEROLA H
SARANTAUS L
PYRHONEN S
PONDER BAJ
MUHONEN T
NEVANLINNA H
Citation: P. Vehmanen et al., A LOW PROPORTION OF BRCA2 MUTATIONS IN FINNISH BREAST-CANCER FAMILIES, American journal of human genetics, 60(5), 1997, pp. 1050-1058
Authors:
HAHKAKEMPPINEN M
MUHONEN T
KANGAS L
PYRHONEN S
Citation: M. Hahkakemppinen et al., CHEMOSENSITIVITY OF HUMAN-MELANOMA METASTASES IN MOUSE SUBRENAL CAPSULE ASSAY - CAN IT PREDICT TUMOR RESPONSE TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY IN METASTATIC MELANOMA, Melanoma research, 6(3), 1996, pp. 215-221
Authors:
PAJARI H
KAARIAINEN H
MUHONEN T
KOSKIMIES O
Citation: H. Pajari et al., ALPORTS-SYNDROME IN 78 PATIENTS - EPIDEMIOLOGIC AND CLINICAL-STUDY, Acta paediatrica, 85(11), 1996, pp. 1300-1306
Authors:
HERNBERG M
MUHONEN T
TURUNEN JP
HAHKAKEMPPINEN M
PYRHONEN S
Citation: M. Hernberg et al., THE CD4+ CD8+ RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY/, Journal of clinical oncology, 14(5), 1996, pp. 1690-1696
Authors:
MUHONEN T
JANTUNEN I
PERTOVAARA H
VOUTILAINEN L
MAICHE A
BLOMQVIST C
PYRHONEN S
KELLOKUMPULEHTINEN P
Citation: T. Muhonen et al., PROPHYLACTIC FILGRASTIM (G-CSF) DURING MITOMYCIN-C, MITOXANTRONE, ANDMETHOTREXATE (MMT) TREATMENT FOR METASTATIC BREAST-CANCER - A RANDOMIZED STUDY, American journal of clinical oncology, 19(3), 1996, pp. 232-234
Authors:
ISOKANGAS OP
MUHONEN T
KAJANTI M
PYRHONEN S
Citation: Op. Isokangas et al., RADIATION-THERAPY OF INTRACRANIAL MALIGNANT-MELANOMA, Radiotherapy and oncology, 38(2), 1996, pp. 139-144
Authors:
KAJANTI M
KALETA R
KANKAANRANTA L
MUHONEN T
HOLSTI L
Citation: M. Kajanti et al., EFFECT OF OVERALL TREATMENT TIME ON LOCAL-CONTROL IN RADICAL RADIOTHERAPY FOR SQUAMOUS-CELL CARCINOMA OF ESOPHAGUS, International journal of radiation oncology, biology, physics, 32(4), 1995, pp. 1017-1023
Authors:
HAHKAKEMPPINEN M
MUHONEN T
VIROLAINEN M
JEKUNEN A
ASKOSELJAVAARA S
PYRHONEN S
Citation: M. Hahkakemppinen et al., RESPONSE OF SUBCUTANEOUS AND CUTANEOUS METASTASES OF MALIGNANT-MELANOMA TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY, British journal of dermatology, 132(6), 1995, pp. 973-977
Authors:
MUHONEN T
HAHKAKEMPPINEN M
PAKKALA S
PYRHONEN S
Citation: T. Muhonen et al., DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 67-73
Authors:
JANTUNEN I
MUHONEN T
Citation: I. Jantunen et T. Muhonen, 5-HT3 RECEPTOR ANTAGONISTS IN THE PROPHYLAXIS OF ACUTE VOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - A RANDOMIZED STUDY, European journal of cancer, 30A(7), 1994, pp. 1041-1042
Authors:
VUORISTO M
JANTUNEN I
PYRHONEN S
MUHONEN T
KELLOKUMPULEHTINEN P
Citation: M. Vuoristo et al., A COMBINATION OF SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA IN THE TREATMENT OF ADVANCED RENAL-CELL CARCINOMA OR MELANOMA, European journal of cancer, 30A(4), 1994, pp. 530-532
Authors:
MUHONEN T
PYRHONEN S
LAASONEN A
WASENIUS VM
ASKOSELJAVAARA S
FRANSSILA K
KANGAS L
Citation: T. Muhonen et al., MOUSE SUBRENAL CAPSULE ASSAY CHEMOSENSITIVITY AND DNA FLOW-CYTOMETRY PARAMETERS OF HUMAN-MELANOMA METASTASES, Acta oncologica, 33(4), 1994, pp. 431-437
Risultati:
1-24
|